Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma
ConditionBleomycin Adverse Reaction
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-12
SponsorAssiut University
About this trial
Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to :
* Clinically based on Change in the Size and Color of Hemangioma. * Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology . * Comparison of Complications associated with Bleomycin and Diode Laser.
Eligibility criteria
Qualifiers
Age between 3 Months and 1 Year old.
Non Complicated Infantile Hemangioma
Disqualifiers
Younger than 3 Months or older than 1 Year.
Complicated Infantile Hemangioma
Trial design
Treatments tested in this trial
- Diode laser
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov